Death, autoantigen modifications, and tolerance.
Autoantibodies present in the serum of patients with a variety of inflammatory diseases have proven useful as diagnostic markers and as probes with which to elucidate biochemical and signaling pathways. The mechanisms governing the generation of autoantibodies remain elusive, constituting a critical missing link in our understanding of rheumatologic illnesses. Several lines of experimentation in recent years have strongly implicated events surrounding cell death in this process. This review will address the potential role played by death-specific modifications of autoantigens in bypassing tolerance to highly conserved autoantigens, including nucleic acids, lipids, and proteins.
Utz
P J
PJ
Department of Medicine, Stanford University School of Medicine, Stanford, California 94305, USA. pjutz@stanford.edu
Gensler
T J
TJ
Anderson
P
P
D000818:Animals; D017209:Apoptosis / Q000276:immunology*; D001324:Autoantigens / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D001327:Autoimmune Diseases / Q000276:immunology* / Q000503:physiopathology*; D020169:Caspases / Q000276:immunology / Q000378:metabolism; D006801:Humans; D012313:RNA / Q000378:metabolism
D001324:Autoantigens; D012313:RNA; D020169:Caspases